ARTICLE | Clinical News
Multaq dronedarone regulatory update
December 7, 2009 8:00 AM UTC
The European Commission approved an MAA from sanofi-aventis for Multaq dronedarone to prevent recurrence of atrial fibrillation or to lower ventricular rate. The company will launch Multaq in January....